ArticleFrontiers in nutrition2026
An extra virgin olive oil diet impairs glycemic control, but mitigates high-fat diet-induced inflammation compared to coconut oil in mice.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Extra virgin olive oil is widely regarded as a metabolically beneficial dietary component due to its anti-inflammatory and antioxidant properties, but its effects on glucose homeostasis remain inconclusive. The aim of this study was to evaluate the impact of an extra virgin olive oil-based high-fat diet (E-HFD) compared to a macronutrient-matched coconut oil-based HFD (C-HFD) on glucose homeostasis and investigate potential underlying mechanisms, including inflammation, gut microbiota, and metabolic partitioning. Methods: Male C57BL/6N mice (5-7 weeks old) were fed E-HFD, C-HFD, or standard chow for up to 5 months. Glucose, insulin, and pyruvate tolerance tests and glucose-stimulated insulin secretion were performed. Immune cells in the perigonadal adipose tissue, colon, and liver were analyzed by flow cytometry. Metabolic partitioning was assessed by analyses of substrate utilization and lipid metabolism. Results: E-HFD-fed mice developed glucose intolerance within 1 week, accompanied by a blunted compensatory insulin response compared to C-HFD, which further deteriorated over time. While C-HFD led to increased adipose tissue and colonic inflammation compared to chow, E-HFD showed only mild or no inflammatory changes. Systemic inflammation and cecal microbiota composition were comparable between the HFD groups. Notably, we found increased hepatic lipid accumulation, upregulation of Conclusions: E-HFD induced pronounced glucose intolerance and a blunted compensatory insulin response, while causing less tissue inflammation than C-HFD compared to standard chow. Neither inflammation nor gut microbiota composition accounted for the observed metabolic impairment. Instead, the altered glucose homeostasis was associated with fatty acid storage and enhanced hepatic lipid accumulation. These findings point toward altered metabolic partitioning and suggest the involvement of a liver-pancreas axis in diet-dependent regulation of glucose homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.